TABLE 2.
ASV | Taxonomy | Group 1a | ARA (%) | Group 2 | ARA (%) | p-value |
ASV198 | p_Proteobacteria;c_Gammaproteobacteria;o_Pseudomonadales;f_Pseudomonadaceae;g_Pseudomonas; | H13 | 0.31416 | Non-H13 | 0.0002 | 1.67E−65 |
ASV404 | p_Proteobacteria;c_Gammaproteobacteria;o_Pseudomonadales;f_Pseudomonadaceae;g_Pseudomonas; | H13 | 0.0995 | Non-H13 | 0.00001 | 3.50E−49 |
ASV101 | p_Proteobacteria;c_Gammaproteobacteria;o_Pseudomonadales;f_Pseudomonadaceae;g_Pseudomonas; | H13 | 0.30347 | Non-H13 | 0.00083 | 2.04E−40 |
ASV11 | p_Proteobacteria;c_Gammaproteobacteria;o_Pseudomonadales;f_Pseudomonadaceae;g_Pseudomonas; | H13 | 4.72383 | Non-H13 | 0.2748 | 1.33E−34 |
ASV539 | p_Bacteroidetes;c_Sphingobacteriia;o_Sphingobacteriales;f_Sphingobacteriaceae;g_Pedobacter; | H13 | 0.01727 | Non-H13 | 0.00034 | 1.88E−27 |
ASV277 | p_Proteobacteria;c_Alphaproteobacteria;o_Caulobacterales;f_Caulobacteraceae; | H14 | 0.14546 | Non-H14 | 0.00026 | 1.18E−102 |
ASV30 | p_Bacteroidetes;c_Flavobacteriia;o_Flavobacteriales;f_Weeksellaceae;g_Chryseobacterium; | H14 | 1.02049 | Non-H14 | 0.00026 | 2.94E−101 |
ASV181 | p_Proteobacteria;c_Alphaproteobacteria;o_Sphingomonadales;f_Sphingomonadaceae;g_Novosphingobium; | H14 | 0.26148 | Non-H14 | 0.00046 | 8.26E−99 |
ASV408 | p_Proteobacteria;c_Alphaproteobacteria;o_Rhizobiales;f_Bradyrhizobiaceae;g_Bradyrhizobium; | H14 | 0.08687 | Non-H14 | 0.00015 | 1.39E−82 |
ASV485 | p_Proteobacteria;c_Betaproteobacteria;o_Burkholderiales;f_Burkholderiaceae; | H14 | 0.06765 | Non-H14 | 0.00007 | 1.50E−73 |
ASV2917 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | NY | 0.08737 | Non-NY | 0.0001 | 1.89E−61 |
ASV3878 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | NY | 0.12115 | Non-NY | 0.00025 | 3.38E−58 |
ASV828 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | NY | 0.1007 | Non-NY | 0.0002 | 1.41E−55 |
ASV1502 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | NY | 0.02389 | Non-NY | 0.00011 | 2.45E−42 |
ASV1154 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | NY | 0.02789 | Non-NY | 0.00009 | 1.68E−40 |
ASV15 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Erwinia; | Tunisia | 3.0591 | Non-Tunisia | 0.00036 | 3.29E−113 |
ASV16 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | Tunisia | 2.70482 | Non-Tunisia | 0.00044 | 1.06E−92 |
ASV27 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | Tunisia | 2.04908 | Non-Tunisia | 0.00323 | 2.38E−71 |
ASV12 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | Tunisia | 3.91837 | Non-Tunisia | 0.00238 | 1.52E−69 |
ASV226 | p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae; | Tunisia | 0.29893 | Non-Tunisia | 0.00005 | 5.24E−67 |
Group 1 is the reference group (samples from a specific sampling site) that will be compared against Group 2 (all other samples that are not from Group 1 sampling site). ARA, average relative abundance. aH13, 2013 samples from Heves, Hungary (n = 20); H14, 2014 samples from Bacs-Kiskun, Hungary (n = 16), NY, 2013 samples from New York, United States (n = 9); Tunisia, 2013 and 2014 samples from Regueb, Tunisia (n = 21).